Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "Covid"

1150 News Found

Study details Proof-of-Concept for Covid-19 detection via saliva screening
Medical Device | February 24, 2022

Study details Proof-of-Concept for Covid-19 detection via saliva screening

Methodology developed by QIMR Berghofer researchers utilizing the Agilent Cary 630 FTIR


MicroLumix’ GermPass kills Covid-19 virus in five seconds
Medical Device | February 23, 2022

MicroLumix’ GermPass kills Covid-19 virus in five seconds

New biotechnology product aims to be world's fastest automatic sanitary solution


Valneva receives funding for Covid-19 vaccine from Scotland
Biotech | February 21, 2022

Valneva receives funding for Covid-19 vaccine from Scotland

The grants are expected to be received over the next three years, commencing March 2022


WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients
Drug Approval | February 20, 2022

WHO grants prequalification of Actemra/RoActemra for critical COVID-19 patients

Since the beginning of the pandemic, more than one million patients with severe COVID-19 have been treated with Actemra/RoActemra


Covid-19 fuels innovative PCR-based detection methods
Medical Device | February 19, 2022

Covid-19 fuels innovative PCR-based detection methods

According to Fortune Business Insights, the launch of new PCR-based detection techniques will lead to a surge in demand for PCR instruments in the coming years


Health Canada authorizes Novavax Covid-19 vaccine
News | February 18, 2022

Health Canada authorizes Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada


Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)
News | February 17, 2022

Moderna’s Covid-19 vaccine approved in Australia for children (6-11 years)

Moderna's vaccine has already received regulatory approval for adults and adolescents in Australia


Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Drug Approval | February 14, 2022

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data


WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
Drug Approval | February 14, 2022

WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19

The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification


Novavax Covid-19 vaccine well tolerated in paediatric population
Biotech | February 11, 2022

Novavax Covid-19 vaccine well tolerated in paediatric population

Immune responses were about two-to-three-fold higher in adolescents than in adults against all variants studied. Vaccine was well-tolerated with no safety signals identified